FOXP3 and melanoma: FoxP3 mRNA-transfected DC vaccines reduced intratumoral, but not systemic, FoxP3+ Treg and bolstered TRP2-specific CTL responses following co-vaccination with TRP2-pulsed DCs in a murine melanoma model (103).